Illumina announced an expansion of its Alliance for Genomic Discovery, committing to add 50,000 genomes paired with proteomic profiles to the consortium’s dataset, generated by DeCode Genetics using Illumina Protein Prep assays. GSK and Amgen are leading the proteomics expansion among alliance members, and Regeneron Genetics Center will join, bringing the core whole‑genome dataset to over 312,000 genomes. The paired genomics‑proteomics resource aims to accelerate target identification and functional follow‑up by linking genetic variation to proteomic consequences. The move reflects growing industry consensus that integrated multi‑omic cohorts are essential for robust human‑genetics‑driven drug discovery and de‑risking translational programs.